Health Care & Life Sciences » Pharmaceuticals | Jiangsu Hengrui Medicine Co. Ltd.

Jiangsu Hengrui Medicine Co. Ltd. A | Ownership

Companies that own Jiangsu Hengrui Medicine Co. Ltd. A

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
OppenheimerFunds, Inc.
111,392,686
3.04%
2,399,504
0.63%
07/31/2018
China Investment Corp. (Investment Management)
34,212,298
0.93%
0
0.96%
09/30/2017
China Asset Management Co., Ltd.
21,344,410
0.57%
-5,725,572
1.06%
06/30/2018
Norges Bank Investment Management
21,177,105
0.57%
-17,152,542
0.03%
12/31/2017
Fidelity Management & Research Co.
20,311,730
0.56%
6,939,427
0.02%
07/31/2018
UBS Asset Management (Hong Kong) Ltd.
15,865,776
0.43%
346,892
3.51%
01/31/2018
Genesis Investment Management LLP
15,426,927
0.42%
-2,703,912
0.73%
12/31/2017
HuaAn Fund Management Co., Ltd.
11,744,790
0.32%
4,863,053
1.55%
12/31/2017
E Fund Management Co., Ltd.
11,152,332
0.31%
-946,876
0.75%
06/29/2018
Harding Loevner LP
10,840,739
0.3%
207,252
0.26%
06/30/2018

About Jiangsu Hengrui Medicine Co.

View Profile
Address
No. 7 Kunlunshan Road
Lianyungang Jiangsu 222000
China
Employees -
Website http://www.hrs.com.cn
Updated 07/08/2019
Jiangsu Hengrui Medicine Co., Ltd. engages in the research, development, manufacture, and sale of drugs. It specializes in antineoplastic agents, surgical anesthesia drugs, features infusion, contrast agents, and cardiovascular drugs. Its products include tablets, oral solution, and suspension of antineoplastic drugs and narcotic drugs; psychotropic substances; soft capsules; freeze-dried powder injection; powder injection; high-volume injection including multi-layer co-extruded infusion bag, with anti-tumor drugs; small volume injections including antineoplastic drugs, psychotropic drugs, and non-final sterilization; biological engineering products such as polyethylene glycol recombinant human granulocyte stimulating factor injection; hard capsules; granules; powder; film and gel.